HRSA Defines "Orphan Drug" For 340B; Purchasing Prohibition Applies Only To Use In Rare Diseases
This article was originally published in The Pink Sheet Daily
Executive Summary
Manufacturers and safety net providers have been uncertain on how to interpret the Affordable Care Act's provision excluding orphan drugs from 340B discounts to newly eligible types of facilities.